HEPH Insider Trading Activity and SEC Form 4 Filings
HEPH insider trading summary
No open-market insider purchases or sales of Hollis Eden Pharmaceuticals Inc (HEPH) have been reported on SEC Form 4 in the past 12 months.
Latest HEPH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 5, 2007 | Robert W Weber | CAO/VP Controller | Sell | $2K (300 @ $5.32) |
| Mar 5, 2007 | Robert W Weber | CAO/VP Controller | Sell | $2K (300 @ $5.29) |
| Mar 5, 2007 | Robert W Weber | CAO/VP Controller | Sell | $2K (300 @ $5.30) |
| Mar 5, 2007 | Robert W Weber | CAO/VP Controller | Sell | $2K (300 @ $5.31) |
| Mar 5, 2007 | Robert W Weber | CAO/VP Controller | Sell | $5K (900 @ $5.33) |
| Mar 5, 2007 | Robert W Weber | CAO/VP Controller | Sell | $2K (300 @ $5.35) |
| Mar 5, 2007 | Robert W Weber | CAO/VP Controller | Sell | $2K (300 @ $5.26) |
| Mar 5, 2007 | Robert W Weber | CAO/VP Controller | Sell | $2K (300 @ $5.27) |
| Feb 14, 2007 | Christopher Reading | Executive VP, Sci. Development | Sell | $1K (193 @ $5.49) |
| Feb 14, 2007 | Daniel D Burgess | COO/CFO | Sell | $9K (1,655 @ $5.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.